1 September 2024
Starpharma presenting at Goldman Sachs Emerging Companies Conference
Melbourne, Australia: Starpharma Holdings Ltd (ASX:SPL; OTCQX:SPHRY) will today present to institutional fund managers at the Goldman Sachs Emerging Companies conference in Sydney.
The invitation-only event involves 35 companies across all sectors. Starpharma is one of three healthcare companies invited to attend - the other two are Blackmores and Sigma Pharmaceuticals.
The presentation will provide an overview of the company, including highlighting:
- Starpharma’s portfolio approach across the pharmaceutical, women’s health and agrochemical industries, and the expanding number of advanced products nearing commercialisation;
- Starpharma’s lead product, VivaGel® for the management of bacterial vaginosis including the first-in-class prevention of recurrence product, commercial progress and symptomatic relief;
- the VivaGel® coated condom product currently under regulatory review and already licensed to Ansell and Okamoto;
- Drug delivery, including Starpharma’s dendrimer-docetaxel nanoparticle formulation; and
- the Agrochemical program, including the recent partnership with Makhteshim Agan.
Download ASX Announcement: Starpharma presenting at Goldman Sachs Emerging Companies Conference ( pdf file, 2MB)